Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Venlafaxine Hydrochloride
Therapeutic Area : Psychiatry/Psychology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Granules India Limited Received ANDA Approval for Venlafaxine ER Capsules
Details : Generic version of Venlafaxine HCl extended-release capsules has been approved which are indicated for the treatment of MDD, GAD, SAD and Panic Disorder (PD).
Product Name : Effexor-Generic
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 19, 2023
Lead Product(s) : Venlafaxine Hydrochloride
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Venlafaxine Hydrochloride
Therapeutic Area : Psychiatry/Psychology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Dr. Reddy's Laboratories Announces the Launch of Venlafaxine ER Tablets in the U.S. Market
Details : Company launched USFDA approved Venlafaxine Hydrochloride-Generic, an selective serotonin and norepinephrine reuptake inhibitors for the treatment of major depressive disorder, generalized anxiety disorder, panic disorder, and social phobia.
Product Name : Venlafaxine Hydrochloride-Generic
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 12, 2021
Lead Product(s) : Venlafaxine Hydrochloride
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Venlafaxine Hydrochloride
Therapeutic Area : Psychiatry/Psychology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Viatris Announces Positive Results from EFFEXOR Study in GAD Patients
Details : Effexor (Venlafaxine HCl) is a serotonin and norepinephrine reuptake inhibitor. It is indicated for the treatment of Generalized Anxiety Disorder.
Product Name : Effexor
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 10, 2024
Lead Product(s) : Venlafaxine Hydrochloride
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable